Mereo BioPharma Group plc

MREO · Nasdaq · SIC 2834: Pharmaceutical Preparations
166
SEC Filings

Business Summary

Core Rare Disease Product CandidatesSetrusumab (BPS-804/UX143) for the Treatment of Osteogenesis ImperfectaTop-line Data from Setrusumab Phase 3 Orbit and Cosmic Studies. We do not know whether our planned clinical trials will begin on time or be completed on schedule, if at all. The commencement, data readouts and completion of clinical trials can be delayed for a number of reasons, including delays related to: inability to generate sufficient preclinical, toxicology, or other in vivo or in vit...

Next Earnings

Q2 FY2026 — expected 2026-08-11

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionMREOdiscussed_in_filing Cybersecurity
topic_mentionMREOdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-192025-12-310001193125-26-115226EDGAR104K words
2025-03-262024-12-310000950170-25-044787EDGAR—
2024-03-272023-12-310000950170-24-037348EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001193125-25-274272EDGAR20K words
2025-08-122025-06-300001193125-25-178489EDGAR—
2025-05-132025-03-310000950170-25-069816EDGAR—
2024-11-122024-09-300000950170-24-124637EDGAR—
2024-08-132024-06-300000950170-24-095777EDGAR—
2024-05-152024-03-310000950170-24-060497EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-270001193125-26-127253EDGAR1K words
2026-03-190001193125-26-115211EDGAR—
2026-02-170001193125-26-054787EDGAR—
2026-01-120001193125-26-009829EDGAR—
2025-12-290001193125-25-332520EDGAR—
2025-11-100001193125-25-274319EDGAR—
2025-08-120000950170-25-106924EDGAR—
2025-07-100000950170-25-094921EDGAR—
2025-05-140000950170-25-071485EDGAR—
2025-05-130000950170-25-069811EDGAR—

166 total filings indexed. 147 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001719714
TickerMREO
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedX0

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 00985b5cc651b8dcb594a5a02328880b39bf1cad3a0aeebc4252a9184ce0acb5
parent: 80bbb3b449f880b5bdd73e0f98ab3a694ab63febf1d6110a1e217601a90d9aa4
content hash: f9c6f80606a975b9df4cd24b065bf835fef67af19e52fd08f96d10eaafa95e9a
signed: 2026-04-13T04:46:20.970Z
sources: 9 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf